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The KCL016 human embryonic stem cell line was derived from an embryo donated for research that carried an
autosomal dominant mutation affecting splicing site of the VHL gene encoding von Hippel–Lindau tumor sup-
pressor E3 ubiquitin protein ligase (676 + 3A N T). The ICM was isolated using laser microsurgery and plated
on γ-irradiated human foreskin ﬁbroblasts. Both the derivation and cell line propagation were performed in an
animal product-free environment. Pluripotent state and differentiation potential were conﬁrmed by in vitro
assays.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Resource table
Name of stem cell
line
KCL016
Institution King's College London, London, UK
Derivation team
Neli Kadeva, Victoria Wood, Glenda Cornwell, Stefano
Codognotto, Emma Stephenson
Contact person
and email
Dusko Ilic, email: dusko.ilic@kcl.ac.uk
Type of resource Biological reagent: cell line
Sub-type Human pluripotent stem cell line
Origin Human embryo
Key marker
expression
Pluripotent stem cell markers: NANOG, OCT4, TRA-1-60,
TRA-1-81, alkaline phosphatase (AP) activity
Authentication Identity and purity of line conﬁrmed
Link to related
literature
(direct URL
links and full
references)
1. Ilic, D., Stephenson, E., Wood, V., Jacquet, L., Stevenson, D.,
Petrova, A., Kadeva, N., Codognotto, S., Patel, H., Semple, M.,
Cornwell, G., Ogilvie, C., Braude, P., 2012. Derivation and
feeder-free propagation of human embryonic stem cells
under xeno-free conditions. Cytotherapy. 14 (1), 122–128.
doi: 10.3109/14653249.2011.623692
http://www.ncbi.nlm.nih.gov/pubmed/22029654
2. Stephenson, E., Jacquet, L., Miere, C., Wood, V., Kadeva, N.,
Cornwell, G., Codognotto, S., Dajani, Y., Braude, P., Ilic, D.,
2012. Derivation and propagation of human embryonic
stem cell lines from frozen embryos in an animal
product-free environment. Nat. Protoc. 7 (7), 1366–1381.
doi: 10.1038/nprot.2012.080
http://www.ncbi.nlm.nih.gov/pubmed/22722371
Information in
public
databases
KCL016 is a National Institutes of Health (NIH) registered hESC
line
NIH registration number: 0216
NIH approval number: NIHhESC-13-0216
http://grants.nih.gov/stem_cells/registry/current.htm?id=656
Ethics
The hESC line KCL016 is derived under license from the UK
Human Fertilisation and Embryology Authority (research
license numbers: R0075 and R0133) and also has local ethical
approval (UK National Health Service Research Ethics
Committee Reference: 06/Q0702/90).
Informed consent was obtained from all subjects and the
experiments conformed to the principles set out in the WMA
Declaration of Helsinki and the NIH Belmont Report. No
ﬁnancial inducements are offered for donation.
2. Resource details
Consent signed Aug 12, 2009
Embryo thawed Aug 23, 2009
UK stem cell bank deposit
approval
Sep 23, 2010
Reference: SCSC10-35
Sex Female 46, XX
Grade Research
Disease status (Fig. 1)
Mutation affecting splicing site of the VHL gene
encoding von Hippel–Lindau tumor suppressor
E3 ubiquitin protein ligase (676 + 3A N T)
Karyotype (aCGH) Imbalance at 8p23.1 (7,256,229–7,729,370)
DNA ﬁngerprint (Table 1)
Allele sizes (in bp) of 16 microsatellite markers
speciﬁc for chromosomes 13, 18 and 21
Viability testing Pass
Pluripotent markers
(immunostaining) (Fig. 2)
NANOG, OCT4, TRA-1-60, TRA-1-81, AP activity
Three germ layer differentiation Endoderm: AFP (α-fetoprotein)
http://dx.doi.org/10.1016/j.scr.2015.12.003
1873-5061/© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Contents lists available at ScienceDirect
Stem Cell Research
j ourna l homepage: www.e lsev ie r .com/ locate /scr
in vitro (immunostaining)
(Fig. 3)
Ectoderm: TUBB3 (tubulin, β3 class III)
Mesoderm: ACTA2 (actin, α2, smooth muscle)
Sibling lines available KCL015, KCL017
We generated KCL016 clinical grade hESC line following protocols,
established previously (Ilic et al., 2012; Stephenson et al., 2012). The ex-
pression of the pluripotencymarkers was tested after freeze/thaw cycle
(Fig. 2). Differentiation potential into three germ layers was veriﬁed
in vitro (Fig. 3).
Molecular karyotyping identiﬁed an imbalance on chromosome
8p23.1 (7,256,229–7,729,370) that was not present in either of two sib-
ling cell lines, KCL015 and KCL017. Imbalance in this region has been
found in normal individuals and is established as benign copy number
variation.
3. Materials and methods
3.1. Consenting process
We distribute Patient Information Sheet (PIS) and consent form to
the in vitro fertilization (IVF) patients if they opted to donate to research
embryos that were stored for 5 or 10 years. They mail signed consent
back to us and that might be months after the PIS and consent were
mailed to them. If in the meantime new versions of PIS/consent are im-
plemented, we do not send these to the patients or ask them to re-sign;
thewhole process is donewith the version thatwas given them initially.
The PIS/consent documents (PGD-V.6) were created on Aug. 10, 2007.
HFEA Code of Practice was in effect at the time of document creation:
Edition 7— R.1 (http://www.hfea.gov.uk/2999.html). The donor couple
signed the consent on Aug. 12, 2009. HFEA Code of Practice was in effect
at the time of donor signature: Edition 7 — R.4. HFEA Code of Practice
Edition 7 — R.1 was in effect until 09 Dec. 2007 and Edition 7 — R.4
was in effect: 02 Oct. 2008–30 Sep. 2009.
3.2. Embryo culture and micromanipulation
Embryo culture and laser-assisted dissection of inner cell mass
(ICM) were carried out as previously described in details (Ilic et al.,
2012; Stephenson et al., 2012). The cellular area containing the ICM
was then washed and transferred to plates containing mitotically
inactivated human neonatal foreskin ﬁbroblasts (HFF).
3.3. Cell culture
ICM plated onmitotically inactivated HFF was cultured as described
(Ilic et al., 2012; Stephenson et al., 2012). TE cells were removed me-
chanically from outgrowth (Ilic et al., 2007, 2010). hES colonies were
expanded and cryopreserved at the third passage.
3.4. Viability test
Straws with the earliest frozen passage (p.2-3) are thawed and new
colonies are counted three days later. These colonies are then expanded
up to passage 8, atwhich point cellswere part frozen and part subjected
to standard battery of tests (pluripotency markers, in vitro and in vivo
differentiation capability, genetics, sterility, mycoplasma).
3.5. Pluripotency markers
Pluripotencywas assessed using two different techniques: enzymat-
ic activity assay [alkaline phosphatase (AP) assay] and immunostaining
as described (Ilic et al., 2012; Stephenson et al., 2012).
Table 1
Genotyping.Microsatellitemarkers speciﬁc for chromosomes 13, 18, 21, X and Ywere am-
pliﬁed. The allele sizes in bp for markers on chromosomes 13, 18, and 21 are listed in the
table.
Chr Marker Allele 1 Allele 2
13
D13S252 294 298
D13S305 443 459
D13S325 288 292
D13S628 453 453
D13S634 403 415
18
D18S386 375 390
D18S390 372 380
D18S391 217 217
D18S535 478 486
D18S819 416 420
D18S976 480 483
D18S978 215 219
21
D21S11 244 248
D21S1409 214 227
D21S1411 311 319
D21S1435 184 184
D21S1437 331 331
Fig. 1. Genetic pedigree tree of the couple undergoing PGD for the VHL syndrome.
Fig. 2. Expression of pluripotency markers. Pluripotency is conﬁrmed by immunostaining
(Oct4, Nanog, TRA-1-60, TRA-1-81) and alkaline phosphatase (AP) activity assay. Actin
stress ﬁbers, visualized with rhodamine–phalloidin (red), are present in both feeders
and hES cell colonies, whereas AP activity (green) is detected only in hES cells. Scale bar,
100 μm.
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3.6. Genotyping
DNA was extracted from hES cell cultures using a Chemagen DNA
extraction robot according to the manufacturer's instructions. Ampliﬁ-
cation of polymorphic microsatellite markers was carried out as de-
scribed (Ilic et al., 2012). Allele sizes were recorded to give a unique
ﬁngerprint of each cell line.
3.7. Array comparative genomic hybridization (aCGH)
aCGH was performed as described in details (Ilic et al., 2012).
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Fig. 3.Differentiation of three germ layers in vitro is conﬁrmed by detection of markers: smoothmuscle actin (red) formesoderm, β-III tubulin (red) for ectoderm andα-fetoprotein (red)
for endoderm. Nuclei are visualized with Hoechst 33342 (blue). Scale bar, 100 μm.
39C. Miere et al. / Stem Cell Research 16 (2016) 37–39
